Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 8-K: Current report
AI-generated summary
Regeneron Pharmaceuticals, Inc. filed a current report on October 30, 2026. The filing announces the issuance of a press release reporting its financial and operating results for the quarter ended September 30, 2026.
Key facts
- Item 2.02 · Results of operations (earnings)
- Item 9.01 · Financial statements and exhibits
More REGN filings
- 144
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
- 4
Filed Oct 15, 2026
- 144
Filed Oct 14, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.